Efficacy and safety of radiofrequency ablation versus surgical sympathectomy in palmar hyperhidrosis

Radiofrequency ablation (RFA) comparative efficacy of treatments using video-assisted thoracoscopic sympathectomy (VATS) in the long term remains uncertain in patients with palmar hyperhidrosis (PHH). This study aimed to compare the efficacy and safety of RFA and VATS in patients with PHH. We recrui...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 14; no. 1; p. 7620
Main Authors Zhong, Yiyue, Zhu, Yanwen, Li, Jiayan, Yang, Xiaowei, Feng, Zhiying, Liu, Haipeng, Liang, Zhu, Lin, Baoquan, Liu, Zhifeng, Wang, Xin, Luo, Weibin, Zhu, Jian, Li, Bin, Lai, Shangdao, Jiang, Weize, Wu, Jiayuan, Li, Daheng, Zhang, Liangqing, Huang, Bing, Tang, Jing
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.04.2024
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Radiofrequency ablation (RFA) comparative efficacy of treatments using video-assisted thoracoscopic sympathectomy (VATS) in the long term remains uncertain in patients with palmar hyperhidrosis (PHH). This study aimed to compare the efficacy and safety of RFA and VATS in patients with PHH. We recruited patients aged ≥ 14 years with diagnosed PHH from 14 centres in China. The treatment options of RFA or VATS were assigned to two cohort in patients with PHH. The primary outcome was the efficacy at 1-year. A total of 807 patients were enrolled. After propensity score matching, the rate of complete remission was lower in RFA group than VATS group (95% CI 0.21–0.57; p  < 0.001). However, the rates of palmar dryness (95% CI 0.38–0.92; p  = 0.020), postoperative pain (95% CI 0.13–0.33; p  < 0.001), and surgery-related complications (95% CI 0.19–0.85; p  = 0.020) were lower in RFA group than in VATS group, but skin temperature rise was more common in RFA group (95% CI 1.84–3.58; p  < 0.001). RFA had a lower success rate than VATS for the complete remission of PHH. However, the symptom burden and cost are lower in patients undergoing RFA compared to those undergoing VATS. Trial Registration: ChiCTR2000039576, URL: http://www.chictr.org.cn/index.aspx .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-024-57834-0